Evaxion Biotech Overview
- Year Founded
-
2008
- Status
-
Public
- Employees
-
62
- Stock Symbol
-
EVAX
- Share Price
-
$4.16
- (As of Thursday Closing)
Evaxion Biotech General Information
Description
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.
Contact Information
Corporate Office
- Drive Neergaards Vej 5 F
- 2970 Hoersholm
- Denmark
Evaxion Biotech Timeline
Evaxion Biotech Stock Performance
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.16 | $4.11 | $2.82 - $18.50 | $21.4M | 5.22M | 681K | -$8.10 |
Evaxion Biotech Financials Summary
|
In Thousands, USD |
TTM 31-Dec-2023 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 25,987 | 25,987 | 42,840 | 94,207 |
| Revenue | 73 | 73 | 0 | 0 |
| EBITDA | (21,557) | (21,557) | (22,585) | (24,207) |
| Net Income | (22,125) | (22,125) | (23,169) | (24,532) |
| Total Assets | 12,889 | 12,889 | 22,025 | 40,163 |
| Total Debt | 10,870 | 10,870 | 10,255 | 3,690 |
Evaxion Biotech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Evaxion Biotech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Evaxion Biotech Comparisons
Industry
Financing
Details
000000
000000
Evaxion Biotech Competitors (11)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BenevolentAI | Formerly PE-Backed | London, United Kingdom | 000 | 00000 | 000000000 | 00000 |
| Cytovac | Venture Capital-Backed | Hørsholm, Denmark | 0 | 000.00 | 0000000000 0 | 000.00 |
| Novavax | Corporation | Gaithersburg, MD | 0000 | 00000 | 000000000 | 00000 |
| Lantern Pharma | Formerly VC-backed | Dallas, TX | 00 | 00000 | 00000000 | 00000 |
| InSilico Medicine | Venture Capital-Backed | Hong Kong, Hong Kong | 000 | 00000 | 00000000 | 00000 |
Evaxion Biotech Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Evaxion Biotech Executive Team (9)
Evaxion Biotech Board Members (9)
| Name | Representing | Role | Since |
|---|---|---|---|
| Marianne Sogaard | Evaxion Biotech | Board Member | 000 0000 |
| Niels Moeller MD | Evaxion Biotech | Board Member | 000 0000 |
| Roberto Prego Pineda | Evaxion Biotech | Board Member | 000 0000 |
Evaxion Biotech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Evaxion Biotech Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Evaxion Biotech FAQs
-
When was Evaxion Biotech founded?
Evaxion Biotech was founded in 2008.
-
Who is the founder of Evaxion Biotech?
Lars Wegner MD and Andreas Mattsson Ph.D are the founders of Evaxion Biotech.
-
Who is the CEO of Evaxion Biotech?
Christian Kanstrup is the CEO of Evaxion Biotech.
-
Where is Evaxion Biotech headquartered?
Evaxion Biotech is headquartered in Hoersholm, Denmark.
-
What is the size of Evaxion Biotech?
Evaxion Biotech has 62 total employees.
-
What industry is Evaxion Biotech in?
Evaxion Biotech’s primary industry is Biotechnology.
-
Is Evaxion Biotech a private or public company?
Evaxion Biotech is a Public company.
-
What is Evaxion Biotech’s stock symbol?
The ticker symbol for Evaxion Biotech is EVAX.
-
What is the current stock price of Evaxion Biotech?
As of 18-Apr-2024 the stock price of Evaxion Biotech is $4.16.
-
What is the current market cap of Evaxion Biotech?
The current market capitalization of Evaxion Biotech is $21.4M.
-
What is Evaxion Biotech’s current revenue?
The trailing twelve month revenue for Evaxion Biotech is $73K.
-
Who are Evaxion Biotech’s competitors?
BenevolentAI, Cytovac, Novavax, Lantern Pharma, and InSilico Medicine are some of the 11 competitors of Evaxion Biotech.
-
What is Evaxion Biotech’s annual earnings per share (EPS)?
Evaxion Biotech’s EPS for 12 months was -$8.10.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
